Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 7 | 2019 | 80 | 2.030 |
Why?
|
| Tissue and Organ Procurement | 3 | 2018 | 35 | 1.750 |
Why?
|
| Attitude of Health Personnel | 3 | 2017 | 155 | 1.140 |
Why?
|
| Hospitals, Urban | 3 | 2018 | 36 | 0.910 |
Why?
|
| Arteriovenous Fistula | 1 | 2022 | 10 | 0.810 |
Why?
|
| Aneurysm | 1 | 2022 | 12 | 0.810 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2022 | 18 | 0.810 |
Why?
|
| Trauma Centers | 2 | 2018 | 7 | 0.780 |
Why?
|
| Kidney Transplantation | 3 | 2023 | 126 | 0.780 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 121 | 0.730 |
Why?
|
| Liver | 2 | 2019 | 184 | 0.730 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2019 | 2 | 0.700 |
Why?
|
| Biliary Tract Diseases | 1 | 2019 | 4 | 0.690 |
Why?
|
| Jejunostomy | 1 | 2019 | 8 | 0.690 |
Why?
|
| Tissue Donors | 4 | 2023 | 81 | 0.660 |
Why?
|
| Education, Medical, Graduate | 2 | 2023 | 88 | 0.650 |
Why?
|
| Kidney Failure, Chronic | 2 | 2020 | 161 | 0.570 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 190 | 0.540 |
Why?
|
| Internship and Residency | 2 | 2023 | 227 | 0.540 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 17 | 0.510 |
Why?
|
| Electroporation | 1 | 2015 | 3 | 0.510 |
Why?
|
| Neoplasm Seeding | 1 | 2015 | 9 | 0.500 |
Why?
|
| Needles | 1 | 2015 | 20 | 0.500 |
Why?
|
| Problem-Based Learning | 1 | 2014 | 7 | 0.480 |
Why?
|
| Models, Educational | 1 | 2014 | 37 | 0.480 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 64 | 0.470 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 91 | 0.470 |
Why?
|
| Graft vs Host Disease | 2 | 2021 | 59 | 0.460 |
Why?
|
| Clinical Competence | 2 | 2023 | 241 | 0.450 |
Why?
|
| General Surgery | 1 | 2014 | 58 | 0.450 |
Why?
|
| Humans | 21 | 2023 | 31070 | 0.420 |
Why?
|
| Pancreas Transplantation | 2 | 2023 | 17 | 0.420 |
Why?
|
| Graft Survival | 2 | 2014 | 98 | 0.420 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2023 | 14 | 0.410 |
Why?
|
| Middle Aged | 10 | 2021 | 10239 | 0.340 |
Why?
|
| Retrospective Studies | 7 | 2022 | 3665 | 0.340 |
Why?
|
| Cold Ischemia | 1 | 2008 | 3 | 0.310 |
Why?
|
| Bile Duct Diseases | 1 | 2008 | 5 | 0.310 |
Why?
|
| Risk Factors | 6 | 2022 | 2593 | 0.310 |
Why?
|
| Brain Death | 1 | 2008 | 17 | 0.310 |
Why?
|
| Female | 11 | 2021 | 17018 | 0.310 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 33 | 0.310 |
Why?
|
| Death | 1 | 2008 | 53 | 0.300 |
Why?
|
| Time Factors | 3 | 2022 | 1681 | 0.290 |
Why?
|
| Surveys and Questionnaires | 3 | 2018 | 1209 | 0.290 |
Why?
|
| Male | 11 | 2021 | 16499 | 0.290 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 230 | 0.280 |
Why?
|
| Patient Selection | 2 | 2019 | 246 | 0.260 |
Why?
|
| United States | 3 | 2021 | 2375 | 0.220 |
Why?
|
| Adult | 6 | 2020 | 8949 | 0.220 |
Why?
|
| Treatment Outcome | 3 | 2022 | 3809 | 0.210 |
Why?
|
| Vascular Patency | 1 | 2022 | 14 | 0.200 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2022 | 24 | 0.200 |
Why?
|
| Organ Transplantation | 1 | 2021 | 39 | 0.190 |
Why?
|
| Age Factors | 2 | 2018 | 874 | 0.190 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 9 | 0.190 |
Why?
|
| Renal Dialysis | 1 | 2022 | 111 | 0.190 |
Why?
|
| Laparotomy | 1 | 2021 | 29 | 0.190 |
Why?
|
| Aged | 7 | 2021 | 10079 | 0.180 |
Why?
|
| Bronchial Fistula | 1 | 2020 | 3 | 0.180 |
Why?
|
| Biliary Fistula | 1 | 2020 | 6 | 0.180 |
Why?
|
| Medicare | 1 | 2021 | 127 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 221 | 0.170 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 32 | 0.170 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 41 | 0.170 |
Why?
|
| Laparoscopy | 1 | 2021 | 171 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2020 | 158 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 52 | 0.160 |
Why?
|
| Heart Diseases | 1 | 2019 | 77 | 0.150 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 20 | 0.150 |
Why?
|
| Health Care Surveys | 1 | 2017 | 68 | 0.150 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 335 | 0.140 |
Why?
|
| Nursing Staff, Hospital | 1 | 2017 | 63 | 0.140 |
Why?
|
| Indiana | 1 | 2016 | 18 | 0.140 |
Why?
|
| Attitude to Health | 1 | 2017 | 99 | 0.140 |
Why?
|
| Cultural Characteristics | 1 | 2016 | 20 | 0.140 |
Why?
|
| Religion and Medicine | 1 | 2016 | 22 | 0.140 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 28 | 0.140 |
Why?
|
| Adolescent | 2 | 2020 | 2403 | 0.130 |
Why?
|
| Young Adult | 2 | 2020 | 2063 | 0.130 |
Why?
|
| Policy | 1 | 2015 | 11 | 0.130 |
Why?
|
| Illinois | 1 | 2016 | 267 | 0.130 |
Why?
|
| Smoking Cessation | 1 | 2015 | 47 | 0.120 |
Why?
|
| Multidetector Computed Tomography | 1 | 2014 | 9 | 0.120 |
Why?
|
| Waiting Lists | 1 | 2014 | 15 | 0.120 |
Why?
|
| End Stage Liver Disease | 1 | 2014 | 12 | 0.120 |
Why?
|
| Coronary Stenosis | 1 | 2014 | 14 | 0.120 |
Why?
|
| Competitive Behavior | 1 | 2014 | 7 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2019 | 718 | 0.120 |
Why?
|
| Coronary Angiography | 1 | 2014 | 99 | 0.120 |
Why?
|
| Smoking | 1 | 2015 | 197 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2014 | 322 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 90 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2014 | 354 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 139 | 0.110 |
Why?
|
| Logistic Models | 2 | 2014 | 410 | 0.100 |
Why?
|
| Graft Rejection | 2 | 2023 | 75 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 818 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 190 | 0.070 |
Why?
|
| Body Weight | 1 | 2008 | 141 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2008 | 123 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 370 | 0.070 |
Why?
|
| Prognosis | 2 | 2020 | 924 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 551 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2023 | 1898 | 0.060 |
Why?
|
| Pancreatic Elastase | 1 | 2023 | 5 | 0.060 |
Why?
|
| C-Peptide | 1 | 2023 | 8 | 0.060 |
Why?
|
| Pancreas | 1 | 2023 | 37 | 0.060 |
Why?
|
| Transplant Recipients | 1 | 2023 | 23 | 0.050 |
Why?
|
| Informed Consent | 1 | 2023 | 22 | 0.050 |
Why?
|
| Weight Gain | 1 | 2023 | 70 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1133 | 0.050 |
Why?
|
| Curriculum | 1 | 2023 | 173 | 0.050 |
Why?
|
| Peritoneum | 1 | 2021 | 18 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2021 | 27 | 0.050 |
Why?
|
| Diaphragm | 1 | 2020 | 8 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 5192 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2020 | 26 | 0.050 |
Why?
|
| Stents | 1 | 2020 | 85 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2019 | 17 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 508 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 138 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 307 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 818 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2014 | 22 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 148 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 244 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 293 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 344 | 0.030 |
Why?
|
| Algorithms | 1 | 2014 | 416 | 0.030 |
Why?
|